Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misoprostol use in developing countries: results from a multicountry study.

J Sherris1, A Bingham, M A Burns

  • 1PATH, Seattle, WA, USA.

International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|December 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025
Same author

Normalized Mutual Information of phonetic sound to distinguish the speech of Parkinson's disease.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020

Women in developing countries often self-medicate with misoprostol for obstetric/gynecologic needs, including abortion. Improved access to evidence-based information on its safe and effective use is crucial for both women and healthcare providers.

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Health
  • Pharmacology

Background:

  • Misoprostol is frequently used off-label for obstetric and gynecologic indications in developing countries.
  • Women often access misoprostol through pharmacies and self-medicate for early abortion induction.
  • While some clinicians express concerns, many acknowledge its role in reducing complications from unsafe abortions.

Purpose of the Study:

  • To identify the information and service delivery needs related to misoprostol use in obstetric/gynecologic care within developing countries.
  • To understand current practices and perceived needs regarding misoprostol among reproductive health providers.

Main Methods:

  • A survey of reproductive health providers across 23 developing countries was conducted.

Related Experiment Videos

  • A qualitative study exploring misoprostol use was performed in four developing countries.
  • Descriptive statistical analysis of survey data and content analysis of qualitative data were employed.

    • Main Results:

    • Women in several developing countries frequently obtain misoprostol from pharmacies for self-managed early abortion.
    • Healthcare providers noted that misoprostol availability has decreased severe complications associated with unsafe abortions.
    • Despite its widespread use, concerns exist among some clinicians regarding self-medication practices.

    Conclusions:

    • Evidence-based information on misoprostol's safety, efficacy, and appropriate dosing for obstetric/gynecologic indications is not readily accessible.
    • Reproductive health providers, including pharmacists, actively seek updated information and guidance on misoprostol.
    • Women require better access to information and counseling regarding the use of misoprostol.